We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+9.61%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$21.6B
AUM Growth
+$2.85B
Cap. Flow
+$1.11B
Cap. Flow %
5.1%
Top 10 Hldgs %
30.93%
Holding
1,357
New
41
Increased
770
Reduced
236
Closed
79

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$188M
2
SNOW icon
Snowflake
SNOW
+$152M
3
IRM icon
Iron Mountain
IRM
+$149M
4
PLD icon
Prologis
PLD
+$131M
5
AMT icon
American Tower
AMT
+$100M

Sector Composition

Rank Sector Weight
1 Real Estate 41.83%
2 Technology 20.16%
3 Communication Services 6.63%
4 Financials 5.64%
5 Consumer Discretionary 5.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMLX icon
1226
Amylyx Pharmaceuticals
AMLX
$2.17B
$1K ﹤0.01%
266
AMRN
1227
Amarin Corp
AMRN
$293M
$1K ﹤0.01%
67
ATAI icon
1228
AtaiBeckley Inc
ATAI
$2.66B
$1K ﹤0.01%
468
AVIR icon
1229
Atea Pharmaceuticals
AVIR
$361M
$1K ﹤0.01%
242
BMEA icon
1230
Biomea Fusion
BMEA
$90.4M
$1K ﹤0.01%
109
CABA icon
1231
Cabaletta Bio
CABA
$445M
$1K ﹤0.01%
175
EDIT icon
1232
Editas Medicine
EDIT
$402M
$1K ﹤0.01%
277
EYPT icon
1233
EyePoint Inc
EYPT
$1B
$1K ﹤0.01%
144
LKFT
1234
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.84B
$1K ﹤0.01%
51
ITOS
1235
DELISTED
iTeos Therapeutics
ITOS
$1K ﹤0.01%
121
LYEL icon
1236
Lyell Immunopharma
LYEL
$318M
$1K ﹤0.01%
46
MGNX icon
1237
MacroGenics
MGNX
$245M
$1K ﹤0.01%
209
MGTX icon
1238
MeiraGTx Holdings
MGTX
$1.09B
$1K ﹤0.01%
130
MXCT icon
1239
MaxCyte
MXCT
$112M
$1K ﹤0.01%
293
NAUT icon
1240
Nautilus Biotechnolgy
NAUT
$152M
$1K ﹤0.01%
362
PAHC icon
1241
Phibro Animal Health
PAHC
$1.48B
$1K ﹤0.01%
38
PGEN icon
1242
Precigen
PGEN
$1.97B
$1K ﹤0.01%
708
QURE icon
1243
uniQure
QURE
$2.52B
$1K ﹤0.01%
158
TERN
1244
DELISTED
Terns Pharmaceuticals
TERN
$1K ﹤0.01%
151
TSHA icon
1245
Taysha Gene Therapies
TSHA
$1.57B
$1K ﹤0.01%
691
VNDA icon
1246
Vanda Pharmaceuticals
VNDA
$310M
$1K ﹤0.01%
191
VYGR icon
1247
Voyager Therapeutics
VYGR
$184M
$1K ﹤0.01%
201
XERS icon
1248
Xeris Biopharma Holdings
XERS
$1.42B
$1K ﹤0.01%
404
XLC icon
1249
State Street Communication Services Select Sector SPDR ETF
XLC
$22.6B
$1K ﹤0.01%
14
XLI icon
1250
State Street Industrial Select Sector SPDR ETF
XLI
$33.3B
$1K ﹤0.01%
10

Similar funds

Daiwa Securities Group's Q3 2024 Portfolio in Review

As of Q3 2024, Daiwa Securities Group held 1,357 positions worth $21.6B, up 15% from $18.8B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Daiwa Securities Group deployed $1.11B of net new capital in Q3 2024, opening 41 new positions and adding to 770 existing holdings. Its largest new stake was Lineage Inc: 465,245 shares worth $36.5M.

By sector, the portfolio is most concentrated in Real Estate at 42% of assets, down from 42% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Tesla, an estimated $188M trimmed.

  • Daiwa Securities Group's largest Q3 2024 buy was Lineage Inc: 465,245 shares worth $36.5M.
  • Daiwa Securities Group added most to CrowdStrike in Q3 2024, an estimated $203M increase.
  • Daiwa Securities Group's biggest Q3 2024 reduction was Tesla, cutting an estimated $188M.
  • Daiwa Securities Group fully exited Lam Research in Q3 2024, selling an estimated $26.6M.
  • Daiwa Securities Group's ten largest holdings make up 31% of its $21.6B portfolio in Q3 2024.
  • Daiwa Securities Group opened 41 new positions and closed 79 in Q3 2024.
  • Daiwa Securities Group's portfolio value rose 15% quarter-over-quarter to $21.6B.

Based on Daiwa Securities Group's 13F filing for Q3 2024, filed 12 Nov 2024.